Bio-Path Holdings, Inc. Gains 126.35%
Wed, Feb 10, 2021 at 05:30 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) soared at $11.77, a gain of 126.3%. On Tue 09 Feb 21, BPTH:NASDAQ hit a New 2-Week High of $5.2. The stock got featured on our News Catalysts scanner on Wed 10 Feb 21 at 02:08 PM in the 'BIOTECH' category. From Tue 26 Jan 21, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Thu 22 Oct 20 at $6.09 with a volume of 49M+, and its share price has been moving sideways in recent weeks.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 187.36%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 126.35%
- United States Antimony Corporation (UAMY:NYSEMKT), 82.56%
- Sundial Growers Inc. (SNDL:NASDAQ), 78.79%
- Tengasco, Inc. (TGC:NYSEMKT), 77.19%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 62.19%
- Tilray, Inc. (TLRY:NASDAQ), 50.91%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 50.53%
- AYRO (AYRO:NASDAQ), 50.2%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 49.05%